BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31049826)

  • 1. First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.
    Funes CJ; Mace RA; Macklin EA; Plotkin SR; Jordan JT; Vranceanu AM
    J Neurooncol; 2019 Jul; 143(3):505-513. PubMed ID: 31049826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live‑video randomized control trial.
    Greenberg J; Carter S; Lester E; Funes CJ; Macklin EA; Plotkin S; Vranceanu AM
    J Neurooncol; 2019 Dec; 145(3):561-569. PubMed ID: 31677033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT.
    Vranceanu AM; Riklin E; Merker VL; Macklin EA; Park ER; Plotkin SR
    Neurology; 2016 Aug; 87(8):806-14. PubMed ID: 27449066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.
    Carter S; Greenberg J; Funes CJ; Macklin EA; Vranceanu AM
    Complement Ther Med; 2021 Jan; 56():102581. PubMed ID: 33197677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mind-Body Therapy via Videoconferencing in Patients With Neurofibromatosis: Analyses of 1-Year Follow-up.
    Lester EG; Gates MV; Vranceanu AM
    Ann Behav Med; 2021 Feb; 55(1):77-81. PubMed ID: 32421171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual mind-body treatment for geographically diverse youth with neurofibromatosis: A pilot randomized controlled trial.
    Lester E; DiStefano S; Mace R; Macklin E; Plotkin S; Vranceanu AM
    Gen Hosp Psychiatry; 2020; 62():72-78. PubMed ID: 31841875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.
    Vranceanu AM; Zale EL; Funes CJ; Macklin EA; McCurley J; Park ER; Jordan JT; Lin A; Plotkin SR
    JMIR Res Protoc; 2018 Oct; 7(10):e11008. PubMed ID: 30355560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.
    Vranceanu AM; Manglani HR; Choukas NR; Kanaya MR; Lester E; Zale EL; Plotkin SR; Jordan J; Macklin E; Bakhshaie J
    JAMA Netw Open; 2023 Jun; 6(6):e2320599. PubMed ID: 37378983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study.
    Vranceanu AM; Merker VL; Plotkin SR; Park ER
    J Neurooncol; 2014 Oct; 120(1):103-9. PubMed ID: 25022450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life (QoL) Assessment in Patients with Neurofibromatosis Type 2 (NF2).
    Cosetti MK; Golfinos JG; Roland JT
    Otolaryngol Head Neck Surg; 2015 Oct; 153(4):599-605. PubMed ID: 25779467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal clinically important difference in the World Health Organization Quality of Life Brief (WHOQOL-BREF) for adults with neurofibromatosis.
    Pietrzykowski MO; Vranceanu AM; Macklin EA; Mace RA
    Qual Life Res; 2024 May; 33(5):1233-1240. PubMed ID: 38214851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program.
    Lester EG; Macklin EA; Plotkin S; Vranceanu AM
    J Neurooncol; 2020 Apr; 147(2):451-457. PubMed ID: 32078086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home practice and quality of life among patients with neurofibromatosis randomized to a mind-body intervention.
    Funes CJ; Zale EL; Luberto CM; Vranceanu AM
    Complement Ther Med; 2019 Feb; 42():114-118. PubMed ID: 30670227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
    Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
    Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of mind-body treatment interventions on quality of life in neurofibromatosis patients: A systematic review and meta-analysis.
    Wei G; Farooq J; Kumar A
    Dermatol Ther; 2021 Jan; 34(1):e14613. PubMed ID: 33258517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.
    Plotkin SR; Duda DG; Muzikansky A; Allen J; Blakeley J; Rosser T; Campian JL; Clapp DW; Fisher MJ; Tonsgard J; Ullrich N; Thomas C; Cutter G; Korf B; Packer R; Karajannis MA
    J Clin Oncol; 2019 Dec; 37(35):3446-3454. PubMed ID: 31626572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of a mind-body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis.
    Zale EL; Pierre-Louis C; Macklin EA; Riklin E; Vranceanu AM
    J Neurooncol; 2018 Apr; 137(2):321-329. PubMed ID: 29275505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can a Dyadic Resiliency Program Improve Quality of Life in Cognitively Intact Dyads of Neuro-ICU Survivors and Informal Caregivers? Results from a Pilot RCT.
    Lester EG; Mace RA; Bannon SM; Popok PJ; Gates MV; Meyers E; Tehan T; Sagueiro D; Rosand J; Macklin EA; Vranceanu AM
    Neurocrit Care; 2021 Dec; 35(3):756-766. PubMed ID: 33880701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of a Live Video Mind-Body Program to a Web-Based Platform for English-Speaking Adults With Neurofibromatosis: Protocol for the NF-Web Study.
    Lester EG; Hopkins SW; Popok PJ; Vranceanu AM
    JMIR Res Protoc; 2021 Jun; 10(6):e27526. PubMed ID: 34110294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.